Breakdown | TTM | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 |
---|---|---|---|---|---|---|
Income Statement | ||||||
Total Revenue | 39.28B | 40.16B | 40.20B | 39.89B | 37.69B | 37.27B |
Gross Profit | 8.30B | 8.40B | 8.59B | 8.00B | 7.21B | 7.34B |
EBITDA | 2.10B | 2.00B | 2.41B | 1.74B | 1.09B | 1.13B |
Net Income | 1.38B | 1.32B | 1.66B | 949.00M | 474.00M | 500.00M |
Balance Sheet | ||||||
Total Assets | 27.57B | 27.56B | 26.57B | 24.16B | 23.59B | 21.19B |
Cash, Cash Equivalents and Short-Term Investments | 1.37B | 1.15B | 1.46B | 1.25B | 1.18B | 1.35B |
Total Debt | 13.45B | 13.34B | 13.66B | 14.48B | 14.91B | 13.69B |
Total Liabilities | 18.93B | 18.77B | 18.96B | 19.51B | 20.16B | 18.52B |
Stockholders Equity | 8.65B | 8.79B | 7.61B | 4.65B | 3.43B | 2.67B |
Cash Flow | ||||||
Free Cash Flow | 0.00 | 588.00M | 1.19B | 538.00M | -1.53B | 1.93B |
Operating Cash Flow | 0.00 | 662.00M | 1.31B | 598.00M | -1.29B | 2.12B |
Investing Cash Flow | 0.00 | -5.00M | -84.00M | -70.00M | -264.00M | -224.00M |
Financing Cash Flow | 0.00 | -1.01B | -1.03B | -484.00M | 1.35B | -1.72B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
---|---|---|---|---|---|---|---|
73 Outperform | ¥7.69B | 10.81 | 4.52% | 0.83% | -20.99% | ||
73 Outperform | ¥7.67B | 5.82 | 4.76% | -0.11% | -19.84% | ||
73 Outperform | ¥9.57B | 5.40 | 3.73% | -2.30% | 16.63% | ||
71 Outperform | ¥8.09B | 19.46 | 4.31% | -3.80% | -9.74% | ||
70 Outperform | ¥7.20B | 11.55 | 2.96% | 0.78% | 106.93% | ||
67 Neutral | £2.83B | 10.37 | 4.69% | 3.46% | 2.40% | -24.53% | |
54 Neutral | ¥4.95B | ― | 0.80% | ― | ― |